research use only

GSK2606414 PERK inhibitor

Cat.No.S7307

GSK2606414 is an orally available, potent, and selective PERK inhibitor with IC50 of 0.4 nM, displaying at least 100-fold selectivity over the other EIF2AKs assayed. This compound impairs GANT-61 induced autophagy in NB cells with MYCN amplification. It exacerbates ER stress-induced apoptosis in HCT116 cells while reduces the apoptosis in SIL1 KD HeLa cells.
Jump to

Quality Control

Batch: Purity: 99.92%
99.92

Solubility in DMSO or Water

In vitro
Batch:

DMSO : 90 mg/mL (199.36 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 19 mg/mL

Water : Insoluble

The solubility data above are all experimental results (not literature values).

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Read more about GSK2606414 solubility in DMSO or water

Working Concentrations for Cell Culture Treatment

Search directly for a cell line, or select a cell line to find matched working concentrations

Read more about GSK2606414 working concentrations for cell culture treatment

×

Selectivity & Specificity

GSK2606414 is a potent inhibitor of PERK, GCN2, RIPK1 (< 1000 nM), c-kit (< 1000 nM), AuroraBkinase (< 1000 nM), BRK (< 1000 nM), MAP3K10 (< 1000 nM), c-MER (< 1000 nM), DDR2 (< 1000 nM), MYLK2 (< 1000 nM), IKBKE (1000 nM), TRKC (1000 nM), MAP3K11 (1000 nM), RET (1000 nM), LCK (1000 nM), NEK4 (1000 nM), MAP4K5 (1000 nM), MAP3K9 (1000 nM), TRKA (1000 nM), AXL (1000 nM), TRKB (1000 nM), YES1 (1000 nM), WNK2 (1000 nM). GSK2606414 exhibits the greatest inhibitory potency toward PERK.

Read more about selectivity & specificity

Mechanism of Action

Information GSK2606414 is a specific PERK inhibitor. It affects the PERK/eIF2α/ATF4/CHOP and ISR signaling pathways by blocking PERK and eIF2α phosphorylation, effectively inhibiting ER stress-induced apoptosis, oxidative stress, and extracellular matrix deposition.
Primary Applications and Mechanism of Action

Read more about GSK2606414 Mechanism of Action

Chemical Information, Storage & Stability

Molecular Weight 451.44 Formula

C24H20F3N5O

Storage (From the date of receipt)
CAS No. 1337531-36-8 Download SDF Storage of Stock Solutions

Synonyms N/A Smiles CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F

Read more about storage & stability

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Read more comparative analysis about GSK2606414

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.